Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP)

MLA

Elio Novembre, et al. “Management of BNT162b2 MRNA COVID-19 Vaccine in Children Aged 5-11 Years with Allergies, Asthma, and Immunodeficiency: Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).” Italian Journal of Pediatrics, vol. 48, no. 1, Feb. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a231a8146fc221015afba0823c0b287&authtype=sso&custid=ns315887.

APA

Elio Novembre, Mariangela Tosca, Carlo Caffarelli, Mauro Calvani, Fabio Cardinale, Riccardo Castagnoli, Elena Chiappini, Claudio Cravidi, Michele Miraglia Del Giudice, Marzia Duse, Amelia Licari, Sara Manti, Alberto Martelli, Giampaolo Ricci, Giuseppe Pingitore, & Gian Luigi Marseglia. (2022). Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). Italian Journal of Pediatrics, 48(1).

Chicago

Elio Novembre, Mariangela Tosca, Carlo Caffarelli, Mauro Calvani, Fabio Cardinale, Riccardo Castagnoli, Elena Chiappini, et al. 2022. “Management of BNT162b2 MRNA COVID-19 Vaccine in Children Aged 5-11 Years with Allergies, Asthma, and Immunodeficiency: Consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).” Italian Journal of Pediatrics 48 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2a231a8146fc221015afba0823c0b287&authtype=sso&custid=ns315887.